Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Double-Blind,Randomized, 12 Week, Bilateral Study of the Safety and Efficacy of AN2728 Ointment B, 2% and 0.5%, Versus Ointment B Vehicle in the Treatment of Patients With Plaque Type Psoriasis

NCT01029405 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT01029405
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01029405 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Double-Blind,Randomized, 12 Week, Bilateral Study of the Safety and Efficacy of AN2728 Ointment B, 2% and 0.5%, Versus Ointment B Vehicle in the Treatment of Patients With Plaque Type Psoriasis
Lead sponsor
Pfizer
Phase
Phase 2
Overall status
Completed
Start date
November 30, 2009
Completion date
June 30, 2010
Enrollment
145 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

psoriasis